Baricitinib for the treatment of cutaneous dermatomyositis: A prospective, open-label study

被引：15
|
作者：
Zhao, Qian [1 ]
Zhu, Zicong [1 ]
Fu, Qiaoyu [1 ]
Shih, Yanting [1 ]
Wu, Dan [1 ]
Chen, Lihong [1 ]
Zheng, Jie [1 ]
Cao, Hua [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, 197 Ruijin 2nd Rd, Shanghai, Peoples R China
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 06期
基金：
中国国家自然科学基金;
关键词：
autoimmune skin disease; baricitinib; CDASI; dermatomyositis; JAK inhibitors;
D O I：
10.1016/j.jaad.2022.08.025
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：1374 / 1376
页数：4
相关论文
共 50 条
  • [21] Levetiracetam in the preventive treatment of transformed migraine: A prospective, open-label, pilot study
    Rapoport, AM
    Sheftell, FD
    Tepper, SJ
    Bigal, ME
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (03): : 212 - 221
  • [22] A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
    Derk, Chris T.
    Grace, Elizabeth
    Shenin, Max
    Naik, Manisha
    Schulz, Steffan
    Xiong, Wen
    RHEUMATOLOGY, 2009, 48 (12) : 1595 - 1599
  • [23] Tacrolimus in the treatment of severe chronic idiopathic urticaria: An open-label prospective study
    Kessel, A
    Bamberger, E
    Toubi, E
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (01) : 145 - 148
  • [24] Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study
    Smith, C. H.
    Jackson, K.
    Bashir, S. J.
    Perez, A.
    Chew, A. L.
    Powell, A. M.
    Wain, M.
    Barker, J. N. W. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (01) : 160 - 169
  • [25] A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency
    Zamboni, Paolo
    Galeotti, Roberto
    Menegatti, Erica
    Malagoni, Anna Maria
    Gianesini, Sergio
    Bartolomei, Ilaria
    Mascoli, Francesco
    Salvi, Fabrizio
    JOURNAL OF VASCULAR SURGERY, 2009, 50 (06) : 1348 - 1358
  • [26] Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study
    Zhang, Zhen-Ning
    Jiang, Xin
    Zhang, Rui
    Li, Xin-Li
    Wu, Bing-Xiang
    Zhao, Qin-Hua
    Wang, Yong
    Dai, Li-Zhi
    Pan, Lei
    Gomberg-Maitland, Mardi
    Jing, Zhi-Cheng
    HEART, 2011, 97 (22) : 1876 - 1881
  • [27] Sodium Oxybate in the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study
    McElroy, Susan L.
    Guerdjikova, Anna I.
    Winstanley, Erin L.
    O'Melia, Anne M.
    Mori, Nicole
    Keck, Paul E., Jr.
    Hudson, James I.
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2011, 44 (03) : 262 - 268
  • [28] A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium
    Sasaki, Y
    Matsuyama, T
    Inoue, S
    Sunami, T
    Inoue, T
    Denda, K
    Koyama, T
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1316 - 1321
  • [29] Prospective open-label study of Nusinersen treatment for adults with Spinal Muscular Atrophy
    Elsheikh, Bakri
    Severyn, Steven
    Arnold, William
    Kolb, Stephen
    Kissel, John
    NEUROLOGY, 2019, 92 (15)
  • [30] Rituximab for refractory polymyositis: An open-label prospective study
    Mok, Chi Chiu
    Ho, Ling Yin
    To, Chi Hung
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (09) : 1864 - 1868
12345